A client with mild symptoms of generalized anxiety disorder would prefer to try a nonpharmacologic intervention rather than daily medication. What alternative suggestions might the psychiatric mental health nurse practitioner offer?

Choice A reason: PRN clonazepam is a benzodiazepine, which is a pharmacological intervention. The client explicitly requested a nonpharmacologic approach. While PRN (as needed) dosing is not "daily" medication, it still involves the use of a controlled substance with risks of dependence and sedation, which does not align with the client’s stated preference for a natural or behavioral treatment modality. Choice B reason: Electroconvulsive therapy is a highly invasive somatic treatment typically reserved for severe, treatment-resistant major depression or catatonia. It is not an appropriate or evidence-based first-line intervention for a client with "mild" generalized anxiety disorder. Suggesting such a significant procedure for mild symptoms would be inconsistent with the standard of care and the principle of least restrictive treatment. Choice C reason: Exposure therapy is the gold-standard behavioral treatment for specific phobias, social anxiety, and PTSD, where the goal is to desensitize the patient to a specific trigger. For generalized anxiety disorder, which involves "free-floating" worry about everyday life rather than a specific object, mindfulness or cognitive-behavioral therapy is generally more effective as an initial nonpharmacologic recommendation. Choice D reason: A meditation app provides a structured platform for mindfulness-based stress reduction, which is a validated nonpharmacologic intervention for mild generalized anxiety. Mindfulness helps the client observe their thoughts without judgment and reduces autonomic arousal. It is an accessible, low-risk, and cost-effective tool that directly addresses the client's request for a behavioral strategy to manage their anxiety symptoms.